We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others... Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. Show more
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire LEXINGTON, Mass., April 5, 2024 LEXINGTON, Mass., April 5, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a...
Curis to Present at Upcoming Healthcare Conferences in April PR Newswire LEXINGTON, Mass., April 4, 2024 LEXINGTON, Mass., April 4, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a...
Curis Provides Fourth Quarter 2023 Business Update PR Newswire LEXINGTON, Mass., Feb. 8, 2024 Emavusertib data presented at ASH showed 3 of 5 patients achieved CR in R/R PCNSL Expansion of...
Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024 PR Newswire LEXINGTON, Mass., Feb. 1, 2024 LEXINGTON, Mass., Feb. 1, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2 | -1.29701686122 | 15.42 | 16.5 | 13.9914 | 20644 | 15.47093879 | CS |
4 | 4.96 | 48.343079922 | 10.26 | 17.49 | 10.02 | 42250 | 14.67657748 | CS |
12 | 5.96 | 64.3628509719 | 9.26 | 17.49 | 8.24 | 35021 | 11.81630529 | CS |
26 | 10.18 | 201.984126984 | 5.04 | 17.49 | 3.8 | 63969 | 10.18686207 | CS |
52 | -4.58 | -23.1313131313 | 19.8 | 19.8 | 3.8 | 177129 | 13.65332351 | CS |
156 | -208.78 | -93.2053571429 | 224 | 348 | 3.8 | 1410306 | 88.88249363 | CS |
260 | -21.18 | -58.1868131868 | 36.4 | 348 | 3.8 | 1573242 | 96.81511716 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions